These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 28431938)

  • 1. Selective inhibition of EZH2 by a small molecule inhibitor regulates microglial gene expression essential for inflammation.
    Arifuzzaman S; Das A; Kim SH; Yoon T; Lee YS; Jung KH; Chai YG
    Biochem Pharmacol; 2017 Aug; 137():61-80. PubMed ID: 28431938
    [TBL] [Abstract][Full Text] [Related]  

  • 2. FTY720 (fingolimod) regulates key target genes essential for inflammation in microglial cells as defined by high-resolution mRNA sequencing.
    Das A; Arifuzzaman S; Kim SH; Lee YS; Jung KH; Chai YG
    Neuropharmacology; 2017 Jun; 119():1-14. PubMed ID: 28373076
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Calcitonin gene-related peptide regulates spinal microglial activation through the histone H3 lysine 27 trimethylation via enhancer of zeste homolog-2 in rats with neuropathic pain.
    An Q; Sun C; Li R; Chen S; Gu X; An S; Wang Z
    J Neuroinflammation; 2021 May; 18(1):117. PubMed ID: 34020664
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dual RNA sequencing reveals the expression of unique transcriptomic signatures in lipopolysaccharide-induced BV-2 microglial cells.
    Das A; Chai JC; Kim SH; Park KS; Lee YS; Jung KH; Chai YG
    PLoS One; 2015; 10(3):e0121117. PubMed ID: 25811458
    [TBL] [Abstract][Full Text] [Related]  

  • 5. EZH2-mediated inhibition of KLF14 expression promotes HSCs activation and liver fibrosis by downregulating PPARγ.
    Du Z; Liu M; Wang Z; Lin Z; Feng Y; Tian D; Xia L
    Cell Prolif; 2021 Jul; 54(7):e13072. PubMed ID: 34031939
    [TBL] [Abstract][Full Text] [Related]  

  • 6. EZH2 inhibitor DZNep modulates microglial activation and protects against ischaemic brain injury after experimental stroke.
    Chen J; Zhang M; Zhang X; Fan L; Liu P; Yu L; Cao X; Qiu S; Xu Y
    Eur J Pharmacol; 2019 Aug; 857():172452. PubMed ID: 31202798
    [TBL] [Abstract][Full Text] [Related]  

  • 7. EZH2 Inhibition Interferes With the Activation of Type I Interferon Signaling Pathway and Ameliorates Lupus Nephritis in NZB/NZW F1 Mice.
    Wu L; Jiang X; Qi C; Zhang C; Qu B; Shen N
    Front Immunol; 2021; 12():653989. PubMed ID: 33868295
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of enhancer of zeste homolog 2 prevents corneal myofibroblast transformation in vitro.
    Liao K; Cui Z; Zeng Y; Liu J; Wang Y; Wang Z; Tang S; Chen J
    Exp Eye Res; 2021 Jul; 208():108611. PubMed ID: 33992624
    [TBL] [Abstract][Full Text] [Related]  

  • 9. No Significant Cytotoxic Effect of the EZH2 Inhibitor Tazemetostat (EPZ-6438) on Pediatric Glioma Cells with Wildtype Histone 3 or Mutated Histone 3.3.
    Wiese M; Schill F; Sturm D; Pfister S; Hulleman E; Johnsen SA; Kramm CM
    Klin Padiatr; 2016 Apr; 228(3):113-7. PubMed ID: 27135271
    [TBL] [Abstract][Full Text] [Related]  

  • 10. GSK343, an inhibitor of EZH2, mitigates fibrosis and inflammation mediated by HIF-1α in human peritoneal mesothelial cells treated with high glucose.
    Wang Q; Xu L; Zhang X; Liu D; Wang R
    Eur J Pharmacol; 2020 Aug; 880():173076. PubMed ID: 32222493
    [TBL] [Abstract][Full Text] [Related]  

  • 11. EZH2 inhibition reduces cartilage loss and functional impairment related to osteoarthritis.
    Allas L; Brochard S; Rochoux Q; Ribet J; Dujarrier C; Veyssiere A; Aury-Landas J; Grard O; Leclercq S; Vivien D; Ea HK; Maubert E; Cohen-Solal M; Boumediene K; Agin V; Baugé C
    Sci Rep; 2020 Nov; 10(1):19577. PubMed ID: 33177650
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synergistic Anti-Tumor Activity of EZH2 Inhibitors and Glucocorticoid Receptor Agonists in Models of Germinal Center Non-Hodgkin Lymphomas.
    Knutson SK; Warholic NM; Johnston LD; Klaus CR; Wigle TJ; Iwanowicz D; Littlefield BA; Porter-Scott M; Smith JJ; Moyer MP; Copeland RA; Pollock RM; Kuntz KW; Raimondi A; Keilhack H
    PLoS One; 2014; 9(12):e111840. PubMed ID: 25493630
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Macrophage/microglial Ezh2 facilitates autoimmune inflammation through inhibition of Socs3.
    Zhang X; Wang Y; Yuan J; Li N; Pei S; Xu J; Luo X; Mao C; Liu J; Yu T; Gan S; Zheng Q; Liang Y; Guo W; Qiu J; Constantin G; Jin J; Qin J; Xiao Y
    J Exp Med; 2018 May; 215(5):1365-1382. PubMed ID: 29626115
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Selective inhibition of EZH2 by EPZ-6438 leads to potent antitumor activity in EZH2-mutant non-Hodgkin lymphoma.
    Knutson SK; Kawano S; Minoshima Y; Warholic NM; Huang KC; Xiao Y; Kadowaki T; Uesugi M; Kuznetsov G; Kumar N; Wigle TJ; Klaus CR; Allain CJ; Raimondi A; Waters NJ; Smith JJ; Porter-Scott M; Chesworth R; Moyer MP; Copeland RA; Richon VM; Uenaka T; Pollock RM; Kuntz KW; Yokoi A; Keilhack H
    Mol Cancer Ther; 2014 Apr; 13(4):842-54. PubMed ID: 24563539
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transcriptome sequencing of microglial cells stimulated with TLR3 and TLR4 ligands.
    Das A; Chai JC; Kim SH; Lee YS; Park KS; Jung KH; Chai YG
    BMC Genomics; 2015 Jul; 16(1):517. PubMed ID: 26159724
    [TBL] [Abstract][Full Text] [Related]  

  • 16. EZH2 Inhibition by Tazemetostat Results in Altered Dependency on B-cell Activation Signaling in DLBCL.
    Brach D; Johnston-Blackwell D; Drew A; Lingaraj T; Motwani V; Warholic NM; Feldman I; Plescia C; Smith JJ; Copeland RA; Keilhack H; Chan-Penebre E; Knutson SK; Ribich SA; Raimondi A; Thomenius MJ
    Mol Cancer Ther; 2017 Nov; 16(11):2586-2597. PubMed ID: 28835384
    [TBL] [Abstract][Full Text] [Related]  

  • 17. EZH2 inhibition in multiple myeloma downregulates myeloma associated oncogenes and upregulates microRNAs with potential tumor suppressor functions.
    Alzrigat M; Párraga AA; Agarwal P; Zureigat H; Österborg A; Nahi H; Ma A; Jin J; Nilsson K; Öberg F; Kalushkova A; Jernberg-Wiklund H
    Oncotarget; 2017 Feb; 8(6):10213-10224. PubMed ID: 28052011
    [TBL] [Abstract][Full Text] [Related]  

  • 18. EZH2 is involved in vulnerability to neuroinflammation and depression-like behaviors induced by chronic stress in different aged mice.
    Wang W; Qin X; Wang R; Xu J; Wu H; Khalid A; Jiang H; Liu D; Pan F
    J Affect Disord; 2020 Jul; 272():452-464. PubMed ID: 32553389
    [TBL] [Abstract][Full Text] [Related]  

  • 19. EZH2 inhibitors restore epigenetically silenced CD58 expression in B-cell lymphomas.
    Otsuka Y; Nishikori M; Arima H; Izumi K; Kitawaki T; Hishizawa M; Takaori-Kondo A
    Mol Immunol; 2020 Mar; 119():35-45. PubMed ID: 31962268
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dysregulated lipid metabolism blunts the sensitivity of cancer cells to EZH2 inhibitor.
    Zhang T; Guo Z; Huo X; Gong Y; Li C; Huang J; Wang Y; Feng H; Ma X; Jiang C; Yin Q; Xue L
    EBioMedicine; 2022 Mar; 77():103872. PubMed ID: 35158113
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.